Neuren Pharmaceuticals (NEU) has received ethics approval to proceed with the phase two clinical study of a treatment for Angelman syndrome in Australia. Angelman syndrome is defined by significant developmental delay and learning difficulties, which manifest as….Read More

Ethical approval on Neuren Pharmaceuticals’ Angelman drug study.

Why April Marks Traditional New Year Across South and Southeast Asia: Solar Calendars, Water Festivals, and Cultural Renewal from Sri Lanka to Bangladesh

Experts Call for Urgent Reform of Africa’s Food Systems Amid Rising Hunger

Blink and You Missed History: 18-Year-Old Gout Gout Explodes to 19.67

From Runways to Revenues: Bluspring’s $13.82 Million Aviation Catering Deal Signals a High-Altitude Growth Play

32 million Visitors and Rising: How the UAE Quietly Became a Global Tourism Powerhouse

Related Articles

3-Million-Cell Map Reveals How Menopause Turns Aging Breast Tissue Cancer-Prone

How Disabling a Cellular “Cleanup” Process Could Make Cancer Cells Visible to the Immune System

Nursery Colds: Do They Boost Kids’ Immunity?

Could your weekend drinks be harming your liver?

New Hope for Advanced Prostate Cancer: Could This Hormone Patch Be a Game-Changer?

BRICS expansion: five countries join, another 25 to follow in 2024

Chinese state media lauds India’s achievements under PM Modi!

Security alarm for India: Bangladesh frees Al-Qaeda terror group chief